Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Skin Diseases, Papulosquamous”

2,155 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,155 results

Very early researchEnded earlyNCT01317017
What this trial is testing

Cell Responses to IFN-gamma

Who this might be right for
Plaque Psoriasis
Rockefeller University 2
Not applicableStudy completedNCT04433442
What this trial is testing

Study to Assess the Safety and Change in Disease Symptoms of Risankizumab (Skyrizi) in Adult Participants With Moderate to Severe Plaque Psoriasis and Psoriatic Arthritis

Who this might be right for
PsoriasisPsoriatic Arthritis
AbbVie 2,324
Not applicableNot Yet RecruitingNCT07567378
What this trial is testing

CARTIZ Registry: Cartilage, Arthropathy and Imaging Under Tirzepatide in Zone-stratified Cohorts - A Four-Institute Mexican Observational Registry

Who this might be right for
Psoriatic ArthritisOsteoarthitisKnee+12 more
JULIO GRANADOS MONTIEL 30
Testing effectiveness (Phase 2)Study completedNCT03381625
What this trial is testing

Topical Application of BMX-010 in Subjects With Atopic Dermatitis and Plaque Psoriasis

Who this might be right for
PsoriasisAtopic Dermatitis
BioMimetix JV, LLC 139
Not applicableStudy completedNCT02656368
What this trial is testing

Safety and Efficacy of SEBORRHEAMEDIS Face Cream in Patients With Seborrheic Dermatitis

Who this might be right for
Seborrheic Dermatitis
Kamedis Ltd. 30
Not applicableStudy completedNCT04758117
What this trial is testing

Assess the Change in Disease State in Adult Participants Being Treated With Oral Upadacitinib Tablets in Participants With Oligo- or Poly-artIcular Psoriatic Arthritis

Who this might be right for
Psoriatic Arthritis
AbbVie 394
Large-scale testing (Phase 3)Looking for participantsNCT07219420
What this trial is testing

Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Palmoplantar Pustulosis

Who this might be right for
Palmoplantar Pustulosis
UCB Biopharma SRL 320
Post-approval studies (Phase 4)Study completedNCT00493324
What this trial is testing

Study to Evaluate the Immune Response to Pneumococcal Vaccine in Alefacept-treated Adults With Chronic Plaque Psoriasis

Who this might be right for
Chronic Plaque Psoriasis
Astellas Pharma Inc 43
Testing effectiveness (Phase 2)Ended earlyNCT02201524
What this trial is testing

Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis

Who this might be right for
Plaque Psoriasis
Pfizer 59
Testing effectiveness (Phase 2)Study completedNCT02785159
What this trial is testing

Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis

Who this might be right for
Psoriasis
Bausch Health Americas, Inc. 152
Not applicableStudy completedNCT05223062
What this trial is testing

Medication Adherence in Psoriatic Arthritis

Who this might be right for
Psoriatic Arthritis
Bezmialem Vakif University 50
Not applicableLooking for participantsNCT04334031
What this trial is testing

Deployment o the Multidisciplinary Prospective Cohort Imminent

Who this might be right for
Chronic Inflammatory DiseaseAngioedemaSevere Asthma+6 more
University Hospital, Lille 2,200
Post-approval studies (Phase 4)Study completedNCT00932113
What this trial is testing

Mechanism of Action Study for Psoriasis

Who this might be right for
Psoriasis
Tufts Medical Center 33
Early research (Phase 1)UnknownNCT02918123
What this trial is testing

Safety of FURESTEM-CD Inj. in Patients With Moderate to Severe Plaque-type Psoriasis

Who this might be right for
Psoriasis
Kang Stem Biotech Co., Ltd. 9
Early research (Phase 1)Ended earlyNCT02649270
What this trial is testing

Tolerability, Safety and Pharmacokinetic Study of Humanized Anti-CD6 Monoclonal Antibody Injection in Chinese Psoriasis

Who this might be right for
Psoriasis
Biotech Pharmaceutical Co., Ltd. 11
Not applicableStudy completedNCT06408454
What this trial is testing

Interleukin- 17 (IL-17), Bcl-3, and NF-kappa-B Inhibitor Zeta (IκBζ) Expression Levels in the Psoriasis Patients

Who this might be right for
PsoriasisPeriodontal Diseases
Kahramanmaras Sutcu Imam University 12
Post-approval studies (Phase 4)Study completedNCT05000086
What this trial is testing

A Pilot Study of Technetium [99Tc] Methylene Diphosphonate in the Treatment of Psoriatic Arthritis

Who this might be right for
Arthritis, Psoriatic
Peking Union Medical College Hospital 20
Large-scale testing (Phase 3)Active Not RecruitingNCT06846541
What this trial is testing

Long-term Safety and Efficacy of ESK-001 in Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque PsoriasisPsoriasis (PsO)Psoriasis+2 more
Alumis Inc 1,680
Early research (Phase 1)Study completedNCT02690142
What this trial is testing

Investigate the Safety, Tolerability and Pharmacokinetics of ABY-035

Who this might be right for
PsoriasisHealthy Subjects
Affibody 72
Early research (Phase 1)Study completedNCT05461456
What this trial is testing

Bioavailability and Tolerability of Fexofenadine Hydrochloride Topical Lotion 1%

Who this might be right for
Atopic DermatitisAtopic Dermatitis EczemaAtopic Rash+9 more
OrchestratePharma GmbH 12
Load More Results